- Home
- GRFX vs PAVM Comparison
GRFX vs PAVM Comparison
Compare GRFX & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFX
- PAVM
- Stock Information
- Founded
- GRFX 1981
- PAVM 2014
- Country
- GRFX Hong Kong
- PAVM United States
- Employees
- GRFX N/A
- PAVM N/A
- Industry
- GRFX
- PAVM Medical/Dental Instruments
- Sector
- GRFX
- PAVM Health Care
- Exchange
- GRFX Nasdaq
- PAVM Nasdaq
- Market Cap
- GRFX 11.9M
- PAVM 12.7M
- IPO Year
- GRFX N/A
- PAVM 2016
- Fundamental
- Price
- GRFX $0.23
- PAVM $0.61
- Analyst Decision
- GRFX
- PAVM Strong Buy
- Analyst Count
- GRFX 0
- PAVM 1
- Target Price
- GRFX N/A
- PAVM $21.00
- AVG Volume (30 Days)
- GRFX 154.4K
- PAVM 105.8K
- Earning Date
- GRFX 01-01-0001
- PAVM 11-14-2024
- Dividend Yield
- GRFX N/A
- PAVM N/A
- EPS Growth
- GRFX N/A
- PAVM N/A
- EPS
- GRFX N/A
- PAVM 0.53
- Revenue
- GRFX $30,019,108.00
- PAVM $4,034,000.00
- Revenue This Year
- GRFX N/A
- PAVM $52.90
- Revenue Next Year
- GRFX N/A
- PAVM $248.84
- P/E Ratio
- GRFX N/A
- PAVM $1.21
- Revenue Growth
- GRFX N/A
- PAVM 166.27
- 52 Week Low
- GRFX $0.14
- PAVM $0.60
- 52 Week High
- GRFX $1.00
- PAVM $4.44
- Technical
- Relative Strength Index (RSI)
- GRFX 43.75
- PAVM 28.70
- Support Level
- GRFX $0.18
- PAVM $0.72
- Resistance Level
- GRFX $0.21
- PAVM $1.25
- Average True Range (ATR)
- GRFX 0.02
- PAVM 0.10
- MACD
- GRFX -0.00
- PAVM -0.03
- Stochastic Oscillator
- GRFX 19.82
- PAVM 1.65
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.